Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

NCT01246557

Conditions
Chronic Disease, Chronic Lymphatic Leukemia, Disease Attributes, +14 more
Locations
  • Centro Médico Teknon Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Universitari Valle Hebron Barcelona, Spain
  • Hospital Clinico Universitario de Barcelona Barcelona, Spain
View Trial Details
Completed

Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old

NCT00590837

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Services maladies du sang, cancérologie, Hôpital Sud, CHU Amiens Amiens, France
  • Service des maladies du sang, Centre Hospitalier Universitaire d'Angers Angers, France
  • Service Hématologie, Centre Hospitalier Annecy Annecy, France
  • C.H Victor Dupouy Argenteuil, France
View all 32 locations
View Trial Details
Completed

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

NCT00920140

Conditions
Cancer, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 28 locations
View Trial Details
Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • New York Presbyterian Hosptial Cornell Med Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
  • Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States
View Trial Details
Completed

A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia

NCT01196013

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Kagoshima University Medical and Dental Hospital Kagoshima, Japan
  • Tokai University Hospital Kanagawa, Japan
View Trial Details
Completed

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

NCT01090167

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Nagoya Daini Red Cross Hospital Aichi, Japan
  • National Hospital Organization Nagoya Medical Center Aichi, Japan
  • University of Fukui Hospital Fukui, Japan
  • Tokai University Hospital Kanagawa, Japan
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details

Related conditions